Artimplant Interim Report January – June 2008

August 7, 2008 |

1 min read

VASTRA FROLUNDA, Sweden--(BUSINESS WIRE)--Regulatory News: • Net revenue for the second quarter amounted to SEK 3.1 million (4.7) and for the first six months to SEK 5.2 million (8.7)*

Earnings Europe

MORE ON THIS TOPIC

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

GSK restructure will hit home, impacting ‘limited’ UK roles

October 28, 2026

·

110 min read

·

BioSpace Editorial Staff

Balance vaccination and anti-vaccination. Vaccination or Anti-vaccination concept, vector illustration

Earnings

GSK vaccine sales miss expectations amid falling demand from adults

October 28, 2026

·

2 min read

·

Nick Paul Taylor

Hand shake icon on wooden cube block which connection with human icon for business deal and agreement concept.

Immuno-oncology

Astellas bets up to $1.34B for option to advance Audax immuno-oncology asset

October 28, 2026

·

2 min read

·

Tristan Manalac

Business growth or increase in professional income, business operations, investment profits or interest on savings, increase in interest rates, businessman holding gold coins forming a growing arrow symbol.

Earnings

Biogen notches 3rd straight quarter of growth thanks to newer products, Apellis

October 28, 2026

·

1 min read

·

Annalee Armstrong